DeCure.ai

The first twelve labs

12 labs. 5,000 diseases. One shared engine.

Each lab owns a disease area, a research queue and one question: which approved medicines deserve a real experiment here? All twelve run on the same evidence, folding and publication infrastructure — and when staking is live, your position decides which of them gets more of the research budget.

Research labs12 labs
01
Coming soonResearch lab

$DeCureCancer Lab

Find combinations that change tumour biology.

Research wedgeApproved-drug combinations, biomarker-defined response, resistance mechanisms and dosing windows.
Why it mattersThe largest lab in the catalogue: 671 diseases where a combination may beat a resistance mechanism.
Research directionComing soon
Enter the lab
02
Coming soonResearch lab

$DeCureLongevity Lab

Test ageing claims against measurable biology.

Research wedgeApproved compounds and combinations linked to defined hallmarks, biomarkers and functional endpoints.
Why it mattersThe field is loud and under-measured. Endpoints decide, not stories.
Research directionComing soon
Enter the lab
03
Coming soonResearch lab

$DeCureRare Lab

Search where the commercial pipeline is thinnest.

Research wedgeMechanism-first repurposing for genetic and ultra-rare diseases with little or no therapeutic development.
Why it matters2,868 diseases — the largest underserved block in the catalogue, and the one the market never reaches.
Research directionComing soon
Enter the lab
04
Coming soonResearch lab

$DeCureAMR Lab

Break resistance without waiting for a new antibiotic.

Research wedgeAntibiotic adjuvants, resistance reversal, biofilm disruption and combination protocols.
Why it mattersNew antibiotics take a decade. Making the existing ones work again does not.
Research directionComing soon
Enter the lab
05
Coming soonResearch lab

$DeCureNeuro Lab

Revisit known drugs against difficult brain biology.

Research wedgeNeuroinflammation, protein homeostasis, synaptic function and stratified disease mechanisms.
Why it matters439 diseases where the biology is hard and the failure rate has been brutal.
Research directionComing soon
Enter the lab
06
Coming soonResearch lab

$DeCureMetabolic Lab

Reuse known pharmacology across connected pathways.

Research wedgeDiabetes, obesity, MASH, mitochondrial biology, timing and combination strategies.
Why it mattersShared pathways mean a candidate can travel between indications.
Research directionComing soon
Enter the lab
07
Coming soonResearch lab

$DeCureNephro Lab

Find new uses in kidney and fluid disorders.

Research wedgeChronic kidney disease, tubular injury, fibrosis, electrolytes and renal inflammation.
Why it mattersMeasurable endpoints and a patient population that has waited a long time.
Research directionComing soon
Enter the lab
08
Coming soonResearch lab

$DeCureImmuno Lab

Re-map known immunomodulators across disease.

Research wedgeAutoimmunity, chronic inflammation, pathway-specific response and patient stratification.
Why it mattersThe same molecule can work in one autoimmune disease and not another. Stratification decides.
Research directionComing soon
Enter the lab
09
Coming soonResearch lab

$DeCureDerma Lab

Turn visible biology into fast experimental feedback.

Research wedgeInflammatory skin disease, fibrosis, wound repair and topical repurposing.
Why it mattersYou can see the endpoint. That makes the first experiment faster and cheaper.
Research directionComing soon
Enter the lab
10
Coming soonResearch lab

$DeCureResp Lab

Search the shared biology behind lung disease.

Research wedgeCOPD, asthma, pulmonary fibrosis and host-response mechanisms.
Why it mattersInflammation and fibrosis recur across the area — one mechanism, several diseases.
Research directionComing soon
Enter the lab
11
Coming soonResearch lab

$DeCurePsych Lab

Test mechanism-led ideas in complex CNS disease.

Research wedgeNeurotransmission, inflammation, metabolism, sleep and biologically defined subgroups.
Why it mattersDiagnoses are broad; mechanisms are not. Subgroups are where a candidate can win.
Research directionComing soon
Enter the lab
12
Coming soonResearch lab

$DeCureCardio Lab

Repurpose against the biology of heart and vessels.

Research wedgeHeart failure, atherosclerosis, remodelling, thrombosis and cardiometabolic disease.
Why it mattersHard endpoints, large trials, and a long record of drugs that worked somewhere else first.
Research directionComing soon
Enter the lab